Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial
Prioritize Healthy Sleep Sleep is one of the most overlooked aspects of metabolic health
Klow vs Glow Peptide: Research Applications When to Choose KLOW for Inflammatory Disease Research Researchers studying inflammatory bowel disease, colitis, Crohns disease models, and epithelial barrier dysfunction choose KLOW over GLOW because of KPVs transporter-mediated gut epithelial uptake and NF-kappaB suppression
Frontiers in Oncology , 12, 858462
cruzi , and in the myocardium of chronically infected animals (Mukherjee et al., 2003
US$ 22.29
US$ 21.68
US$ 29.86
US$ 27.29
US$ 28.70
US$ 22.55
